Table 3.
Study | Patient (n) | Agent | Complete obliteration rate | Complication rate |
---|---|---|---|---|
Sirakov et al. [21] (2019) | 27 | PHIL 25 | 52% | 22.2% |
Koçer et al. [5] (2016) | 3 | PHIL | 0% (mean obliteration 80%) | 0% |
Akmangit et al. [7] (2014) | 16 | Squid 18 | 37.5% | 12.5% (intracranial hemorrhage) |
Squid 12 | ||||
Samaniego et al. [6] (2016) | 5 | PHIL | 60% | 0% |
AVM, arteriovenous malformation; PHIL, precipitating hydrophobic injectable liquid.